United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Apr 17, 2026 · Filed Apr 20, 2026

On Apr 17, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$586.66 for US$5.57M under a trading plan, leaving 40,513 shares. Filed Apr 20, 2026 (Form 4).

Sold
9,500 shares
Price
US$586.66 average (US$575.38 to US$592.30)
Value
US$5.57M
Holding after
40,513 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 17, 2026Common StockOption exercise9,500US$146.0350,013Direct
Apr 17, 2026Common StockSale248US$575.3849,765Direct
Apr 17, 2026Common StockSale640US$576.1449,125Direct
Apr 17, 2026Common StockSale307US$577.0648,818Direct
Apr 17, 2026Common StockSale143US$578.1448,675Direct
Apr 17, 2026Common StockSale82US$579.0548,593Direct
Apr 17, 2026Common StockSale20US$579.7948,573Direct
Apr 17, 2026Common StockSale40US$583.6348,533Direct
Apr 17, 2026Common StockSale159US$585.3348,374Direct
Apr 17, 2026Common StockSale888US$586.2147,486Direct
Apr 17, 2026Common StockSale1,715US$587.4945,771Direct
Apr 17, 2026Common StockSale2,072US$588.4443,699Direct
Apr 17, 2026Common StockSale2,088US$589.3241,611Direct
Apr 17, 2026Common StockSale777US$590.2840,834Direct
Apr 17, 2026Common StockSale121US$591.1040,713Direct
Apr 17, 2026Common StockSale200US$592.3040,513Direct

Source

View original at SEC

Related